tradingkey.logo

BRIEF-Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives

ReutersFeb 5, 2025 12:36 PM

- Zenas Biopharma Inc ZBIO.O:

  • ZENAS BIOPHARMA- CASH EQUIVALENTS, SHORT-TERM INVESTMENTS AS OF DEC 31 TO FUND OPERATING EXPENSES & CAPEX REQUIREMENTS INTO Q4 2026

Source text: ID:nGNE7m1MRZ

Further company coverage: ZBIO.O

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI